eXmoor Pharma
Bristol, United Kingdom
Compare Cell Therapy CDMOs in Europe
Compare Cell Therapy CDMOs in UK
Compare AAV CDMOs in Europe
Compare AAV CDMOs in UK
Program data pending ClinicalTrials.gov matching
· Last scored 2026-10-29
78.1
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (3)
○ EMA GMP
✓ MHRA GMP (1)
Quick Facts: eXmoor Pharma
- Signal Score
- 78.1/100 (as of 2026-10-29)
- Quality Compliance
- 100.0/100
- Headquarters
- Bristol, United Kingdom
- Modalities
- Cell Therapy, AAV
- Active Programs
- No ClinicalTrials.gov matches confirmed — 1 partnership signal in press (announcements, not verified)
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About eXmoor Pharma
Pure-play CDMO.
Signal Score & Pillar Breakdown
Quality Compliance
100.0
FDA InspectionsNo US records on file
MHRA GMP Certificates1 on record
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer. 1 partnership announcement found in press monitoring.
Programs
— no verified data
Sponsors— no verified data
ModalitiesCell Therapy, AAV
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Partnership Signals (from press monitoring)
Company announcements, not verified evidence.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
58.0
1 manufacturing site: Bristol, UK
Modalities: Cell Therapy, AAV
Capacity assessment: 58.0/100
Sites: Bristol, UK
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
Press Signals3 articles (not scored)
1 manufacturing site: Bristol, UK
Modalities: Cell Therapy, AAV
Capacity assessment: 58.0/100
eXmoor Pharma MHRA GMP Compliance 1 certificates
2025-11
Compliant
Non-Compliant
| Certificate | Site | City / Postcode | Inspection Date | Status |
|---|---|---|---|---|
| UK MIA(IMP) 32954 Insp GMP/IMP 32954/36082496-0002[I] | EXMOOR PHARMA CONCEPTS LTD | BRISTOL BS34 5TA | 2025-11-12 | COMPLIANT |
Source: MHRA GMDP Database · Retrieved Nov 22, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Nov 21, 2026
Company Signals 3 articles
Company announcements, not verified evidence. They do not change any score.
eXmoor Pharma and Royal Free London’s CVIC Form Strategic Partnership to Streamline UK Cell and Gene Therapy Manufacturing - BioPharma APAC
eXmoor Pharma and Royal Free London’s CVIC Form Strategic Partnership to Streamline UK Cell and Gene Therapy Manufacturing BioPharma APAC
eXmoor Pharma appoints Manuel Balbuena as Chief Commercial Officer - Pharmafile
eXmoor Pharma appoints Manuel Balbuena as Chief Commercial Officer Pharmafile
eXmoor Pharma Appoints Manuel Balbuena Chief Commercial Officer - Contract Pharma
eXmoor Pharma Appoints Manuel Balbuena Chief Commercial Officer Contract Pharma
Frequently Asked Questions About eXmoor Pharma
Does eXmoor Pharma hold EMA or MHRA GMP certificates?
CDMO Signal tracks 1 MHRA GMP certificate for eXmoor Pharma.
What is eXmoor Pharma's CDMO Signal Score?
eXmoor Pharma has a Signal Score of 78/100, based on quality, operations, financial stability, and capacity data.
Evaluating eXmoor Pharma for a manufacturing program?
Use the free AI matchmaker to compare eXmoor Pharma against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Rose BioSolutions
Rockville, MD · Memphis, TN · Keele, United Kingdom
Signal Score: 64.0
AAV, Lentiviral, Adenoviral, Plasmid, Cell Therapy, CAR-T
Cell and Gene Therapy Catapult
Stevenage, United Kingdom
Signal Score: 59.0
CAR-T, Cell Therapy, AAV
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
Takeda
Boston, MA · Zurich, CH
Signal Score: 83.4
AAV, Cell Therapy
WuXi Biologics
Shanghai, CN · Wuxi, CN
Signal Score: 82.7
CAR-T, Cell Therapy, AAV, ADC, Monoclonal Antibody
Compare eXmoor Pharma with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.